Work

Baseline CD8 lymph node avidity with 89-Zr-crefmirlimab in patients with metastatic renal cell carcinoma and response to IO therapy.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.4_suppl.375

Authors: Peter D. Zang, Przemyslaw Twardowski, Delphine L Chen, Evan Thomas Hall, David Hays, Ian Wilson, Kristin Schmiedehausen, Michael Ferris, William Le, Michael A. Postow, Sumanta Kumar Pal

Institutions: City Of Hope National Medical Center, City of Hope, University of Washington, Fred Hutch Cancer Center, Central Arkansas Radiation Therapy Institute, ImaginAb (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4391303161

Cites:

Cited by: 2

Related to: 10